Cargando…
A Clinical Diagnostic Study: Fibulin-2 is a Novel Promising Biomarker for Predicting Infection
INTRODUCTION: Infection remains a major cause of morbidity and mortality in hospital. As uncontrolled early infection may develop into systemic infection and eventually progress to sepsis, it is important to address infection at an early stage. Furthermore, early detection and prompt diagnosis of in...
Autores principales: | Li, Shidan, Jiang, Hao, Xing, Wei, Wang, Shaochuan, Zhang, Yao, Li, Youbin, Mao, Chengyi, Zeng, Delian, Lan, Ping, Tang, Dongqin, Zhan, Jijie, Li, Lei, Xu, Xiang, Fei, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8931586/ https://www.ncbi.nlm.nih.gov/pubmed/35303288 http://dx.doi.org/10.1007/s40121-022-00622-y |
Ejemplares similares
-
Fibulin‐2: A potential regulator of immune dysfunction after bone trauma
por: Li, Shidan, et al.
Publicado: (2023) -
Cathepsin F and Fibulin-1 as novel diagnostic biomarkers for brain metastasis of non-small cell lung cancer
por: Wei, Song, et al.
Publicado: (2022) -
Fibulin-2 Facilitates Malignant Progression of Hepatocellular Carcinoma
por: Hu, Xinyan, et al.
Publicado: (2023) -
Fibulin-3 as a biomarker of response to treatment in malignant mesothelioma
por: Kovac, Viljem, et al.
Publicado: (2015) -
Plasma Fibulin-3 as a Potential Biomarker for Patients with Asbestos-Related Diseases in the Han Population
por: Jiang, Zhaoqiang, et al.
Publicado: (2017)